Wiskott Aldrich Syndrome clinical trials

Explore recruiting wiskott aldrich syndrome clinical trials.

Recruiting wiskott aldrich syndrome studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Wiskott Aldrich Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Single Arm, Open Label Clinical Study of Hematopoietic Stem Cell Gene Therapy with Cryopreserved Autologous CD34+ Cells Transduced with Lentiviral Vector encoding WAS cDNA in Subjects with Wiskott-Aldrich Syndrome (WAS)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Long-term Follow-up Study for Subjects Previously Treated with Autologous ex vivo Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Long term safety follow up of patients enrolled in the phase I/II clinical trial of haematopoietic stem cell gene therapy for the Wiskott-Aldrich Syndrome (GTG002-07 and GTG003-08)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Wiskott Aldrich Syndrome trials by city

Wiskott Aldrich Syndrome in Toronto Wiskott Aldrich Syndrome in Vancouver Wiskott Aldrich Syndrome in Montreal Wiskott Aldrich Syndrome in Calgary Wiskott Aldrich Syndrome in Edmonton Wiskott Aldrich Syndrome in Ottawa Wiskott Aldrich Syndrome in Winnipeg Wiskott Aldrich Syndrome in Quebec City Wiskott Aldrich Syndrome in Hamilton Wiskott Aldrich Syndrome in Kitchener Wiskott Aldrich Syndrome in London Wiskott Aldrich Syndrome in Halifax Wiskott Aldrich Syndrome in New York Wiskott Aldrich Syndrome in Los Angeles Wiskott Aldrich Syndrome in Chicago Wiskott Aldrich Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease